Circulating Biomarkers in Coronary Microvascular Dysfunction
Coronary microvascular dysfunction is an underdiagnosed pathologic process that is associated with adverse clinical outcomes. Biomarkers, molecules measurable in the blood, could inform the clinician by aiding in the diagnosis and management of coronary microvascular dysfunction. We present an updat...
Main Authors: | Teja Chakrala, Roshni Prakash, Carlos Valdes, Carl J. Pepine, Ellen C. Keeley |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-06-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.122.029341 |
Similar Items
-
Critical role of the coronary microvasculature in heart disease: From pathologic driving force to “innocent” bystander
by: Roshni O. Prakash, et al.
Published: (2022-10-01) -
Identification of Circulating Diagnostic Biomarkers for Coronary Microvascular Disease in Postmenopausal Women Using Machine-Learning Techniques
by: Alicia Arredondo Eve, et al.
Published: (2021-05-01) -
Single Nucleotide Polymorphisms in Coronary Microvascular Dysfunction
by: Andrew P. Stein, et al.
Published: (2024-02-01) -
Trans-myocardial omega-3 fatty acid gradient in coronary microvascular dysfunction
by: Ellen C. Keeley, et al.
Published: (2022-10-01) -
Advances and Challenges in Biomarkers Use for Coronary Microvascular Dysfunction: From Bench to Clinical Practice
by: Erica Rocco, et al.
Published: (2022-04-01)